Intercept Pharmaceuticals, Inc.
Farnesoid X receptor modulators

Abstract:

The present invention provides a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are as described herein. The present invention relates generally to selective FXR agonists and to methods of making and using them.